Literature DB >> 17020974

Gene expression profiles of primary breast carcinomas from patients at high risk for local recurrence after breast-conserving therapy.

Bas Kreike1, Hans Halfwerk, Petra Kristel, Annuska Glas, Hans Peterse, Harry Bartelink, Marc J van de Vijver.   

Abstract

PURPOSE: Several risk factors for local recurrence of breast cancer after breast-conserving therapy (BCT) have been identified. The identification of additional risk factors would be very useful in guiding optimal therapy and also in improving understanding of the mechanisms underlying local recurrence. We used cDNA microarray analysis to identify gene expression profiles associated with local recurrence. EXPERIMENTAL
DESIGN: Using 18K cDNA microarrays, gene expression profiles were obtained from 50 patients who underwent BCT. Of these 50 patients, 19 developed a local recurrence; the remaining 31 patients were selected as controls as they were free of local recurrence at least 11 years after treatment. For 9 of 19 patients, the local recurrence was also available for gene expression profiling. Unsupervised and supervised methods of classification were used to separate patients in groups corresponding to disease outcome and to study the overall gene expression pattern of primary tumors and their recurrences.
RESULTS: Hierarchical clustering of patients did not show any grouping reflecting local recurrence status. Supervised analysis revealed no significant set of genes that was able to distinguish recurring tumors from nonrecurring tumors. Paired-data analysis of primary tumors and local recurrences showed a remarkable similarity in gene expression profile between primary tumors and their recurrences.
CONCLUSIONS: No significant differences in gene expression between primary breast cancer tumors in patients with or without local recurrence after BCT were identified. Furthermore, analyses of primary tumors and local recurrences show a preservation of the overall gene expression pattern in the local recurrence, even after radiotherapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17020974     DOI: 10.1158/1078-0432.CCR-06-0805

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  20 in total

1.  Telomere length variation in normal epithelial cells adjacent to tumor: potential biomarker for breast cancer local recurrence.

Authors:  Xin Zhou; Alan K Meeker; Kepher H Makambi; Ourania Kosti; Bhaskar V S Kallakury; Mary K Sidawy; Christopher A Loffredo; Yun-Ling Zheng
Journal:  Carcinogenesis       Date:  2011-11-09       Impact factor: 4.944

2.  Metabolic shifts in residual breast cancer drive tumor recurrence.

Authors:  Kristina M Havas; Vladislava Milchevskaya; Ksenija Radic; Ashna Alladin; Eleni Kafkia; Marta Garcia; Jens Stolte; Bernd Klaus; Nicole Rotmensz; Toby J Gibson; Barbara Burwinkel; Andreas Schneeweiss; Giancarlo Pruneri; Kiran R Patil; Rocio Sotillo; Martin Jechlinger
Journal:  J Clin Invest       Date:  2017-05-15       Impact factor: 14.808

3.  Global profiling of signaling networks: study of breast cancer stem cells and potential regulation.

Authors:  Hongxia Wang; Mingzhu Huang; David Y Zhang; Fengchun Zhang
Journal:  Oncologist       Date:  2011-06-10

4.  Isolation and proteomic analysis of platelets by SELDI-TOF MS.

Authors:  Sean R Downing; Giannoula L Klement
Journal:  Methods Mol Biol       Date:  2012

5.  Linking the septin expression with carcinogenesis.

Authors:  Ming Liu; Suqin Shen; Fang Chen; Wenbo Yu; Long Yu
Journal:  Mol Biol Rep       Date:  2010-02-27       Impact factor: 2.316

6.  Validation of a radiosensitivity molecular signature in breast cancer.

Authors:  Steven A Eschrich; William J Fulp; Yudi Pawitan; John A Foekens; Marcel Smid; John W M Martens; Michelle Echevarria; Vidya Kamath; Ji-Hyun Lee; Eleanor E Harris; Jonas Bergh; Javier F Torres-Roca
Journal:  Clin Cancer Res       Date:  2012-07-25       Impact factor: 12.531

7.  Risk stratification in ductal carcinoma in situ: the role of genomic testing.

Authors:  Gary M Freedman
Journal:  Curr Oncol Rep       Date:  2013-02       Impact factor: 5.075

8.  Postmastectomy irradiation in breast in breast cancer patients with T1-2 and 1-3 positive axillary lymph nodes: is there a role for radiation therapy?

Authors:  Rusen Cosar; Cem Uzal; Fusun Tokatli; Bengu Denizli; Mert Saynak; Nesrin Turan; Sernaz Uzunoglu; Alaattin Ozen; Atakan Sezer; Kamuran Ibis; Burcu Uregen; Vuslat Yurut-Caloglu; Zafer Kocak
Journal:  Radiat Oncol       Date:  2011-03-30       Impact factor: 3.481

Review 9.  Commercially Available Gene Expression Assays as Predictive Tools for Adjuvant Radiotherapy? A Critical Review.

Authors:  David Krug; René Baumann; Wilfried Budach; Marciana Nona Duma; Jürgen Dunst; Petra Feyer; Rainer Fietkau; Wulf Haase; Wolfgang Harms; Thomas Hehr; Marc D Piroth; Felix Sedlmayer; Rainer Souchon; Frederik Wenz; Rolf Sauer
Journal:  Breast Care (Basel)       Date:  2020-01-24       Impact factor: 2.860

10.  Which patients might benefit from postmastectomy radiotherapy in breast cancer patients with t1-2 tumor and 1-3 axillary lymph nodes metastasis?

Authors:  Moonkyoo Kong; Seong Eon Hong
Journal:  Cancer Res Treat       Date:  2013-06-30       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.